Skip to main content

  • A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease

    • Posted: 12/01/2021
    • Author:

      Brian J. Forrestal, Cheng Zhang, Brian C. Case, Charan Yerasi, Paige E. Craig, Rebecca Torguson, Nelson L. Bernardo and Ron Waksman

    • CRM2021

    Abstract

    Background

    Recent meta-analyses have raised concerns about mortality with paclitaxel drug-coated balloons (DCB). This pooled, patient-level analysis of the BIOLUX P-I, P-II, and P-III studies was performed to evaluate the safety and efficacy of Passeo-18 Lux DCB.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details